Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropa Metals Regulatory News (EUZ)

  • This share is currently suspended. It was suspended at a price of 1.025
  • There is currently no data for EUZ

Annual Financial Report

31 Oct 2025 13:15

RNS Number : 7407F
Europa Metals Ltd
31 October 2025
 

 31 October 2025

Europa Metals Ltd

("Europa Metals", the "Company" or the "Group") (AIM, AltX: EUZ)

Final Results for the Year Ended 30 June 2025

 

 

Europa Metals is pleased to announce its final results for the year ended 30 June 2025.

A pdf copy of the full audited Annual Report and Accounts is available at the following link: http://www.rns-pdf.londonstockexchange.com/rns/7407F_1-2025-10-31.pdf and on the Company website https://www.europametals.com/news-announcements/annual-reports-archive. It will shortly be posted to shareholders who have requested hard copies. The Company will advise of the timing and location of its 2025 Annual General Meeting in due course

For further information on the Company, please visit www.europametals.com or contact:

Europa Metals Ltd

Dan Smith, Non-Executive Director and Company Secretary (Australia)

T: +61 8 9486 4036

E: dsmith@europametals.com

 

Myles Campion, Executive Chairman and acting CEO (UK)

E: mcampion@europametals.com

 

 

Beaumont Cornish (Nominated Adviser/Broker)

James Biddle/Roland Cornish

T: +44 (0) 20 7628 3396

 

Questco Corporate Advisory Proprietary Limited (JSE Sponsor)

Amanda Mahlunge

T: +27 84 287 2718

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

 

Key Extracts from the Company's audited Report and Accounts are set out below:

Consolidated Statement of Profit or Loss and Other Comprehensive Income For the year ended 30 June 2025

 

 

2025

2024

Note

$

$

 

Other income

-

277,071

Other gains

3(a)

5,575,725

-

5,575,725

277,071

 

Fair value loss on financial assets

9

(1,432,534)

-

 

Exploration expenditure

-

(15,935)

Foreign exchange gain/(loss)

(16,597)

(445)

Other expenses

3(b)

(991,444)

(893,471)

Profit/(loss) before income tax

3,135,150

(632,780)

Income tax benefit / (expense)

5

-

-

Net profit/(loss) for the year

3,135,150

(632,780)

 

 

 

Other comprehensive income

 

 

Items that may be reclassified subsequently to profit or loss

 

Net exchange (loss)/gain on translation of foreign operation

-

-

Other comprehensive income for the year, net of tax

-

-

Total comprehensive profit/(loss) for the year

3,135,150

(632,780)

 

 

Net profit/(loss) for the year attributable to:

 

Equity holders of the Parent

3,135,150

(632,780)

 

3,135,150

(632,780)

Total comprehensive profit/(loss) for the year attributable to:

 

Equity holders of the Parent

3,135,150

(632,780)

 

3,135,150

(632,780)

Loss per share

Cents per share

Cents per share

 

Basic profit/(loss) for the year attributable to ordinary equity holders of the Parent

7

3.19

(0.66)

Diluted profit/(loss) for the year attributable to ordinary equity holders of the Parent

7

3.13

(0.66)

The above Consolidated Statement of Profit or Loss and Other Comprehensive Income should be read in conjunction with the accompanying notes

Consolidated Statement of Financial Position

As at 30 June 2025

 

 

2025

2024

Note

$

$

Assets

 

 

Current assets

Cash and cash equivalents

8

1,403,949

252,075

Trade and other receivables

10

69,155

64,673

Financial assets at FVTPL

9

2,090,640

-

Total current assets

 

3,563,744

316,748

 

Total assets

3,563,744

316,748

 

 

Liabilities and equity

 

Current liabilities

 

Trade and other payables

12

113,141

310,773

Borrowings

13

209,197

-

Total current liabilities

 

322,338

310,773

 

Total liabilities

 

322,338

310,773

 

Net assets

3,241,406

5,975

 

 

Equity

 

Contributed equity

14

49,662,517

49,562,236

Accumulated losses

17

(46,463,740)

(52,856,850)

Reserves

16

42,629

3,300,589

Total equity

 

3,241,406

5,975

 

The above Consolidated Statement of Financial Position is to be read in conjunction with the accompanying notes in the full Annual Report and Accounts.

Consolidated Statement of Cash Flows

For the year ended 30 June 2025

 

2025

2024

Note

$

$

Cash flows used in operating activities

Receipts from associate

-

277,071

Exploration and evaluation expenditure

-

(4,792)

Payments to suppliers and employees

(1,102,418)

(672,095)

Net cash flows used in operating activities

20

(1,102,418)

(399,816)

 

Cash flows used in investing activities

 

Proceeds from sale of equity investments

2,052,551

-

Net cash flows used in investing activities

 

2,052,551

-

 

Cash flows from financing activities

 

Proceeds from borrowings

224,161

-

Net cash flows from financing activities

224,161

-

 

Net increase/(decrease) in cash and cash equivalents held

1,174,294

(399,816)

Net foreign exchange difference

(22,420)

(2,099)

Cash and cash equivalents at 1 July

252,075

653,990

Cash and cash equivalents at 30 June

8

1,403,949

252,075

 

 

 

The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes in the full Annual Report and Accounts which can be accessed via the following link: https://www.europametals.com/news-announcements/annual-reports-archive and via http://www.rns-pdf.londonstockexchange.com/rns/7407F_1-2025-10-31.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR MBBJTMTMJBRA
Date   Source Headline
21st Dec 20227:00 amRNSPublication of Supplementary Explanatory Statement
7th Dec 202210:00 amRNSNotice of General Meeting
30th Nov 20225:30 pmRNSResults of Annual General Meeting
30th Nov 20227:00 amRNSUpdated Mineral Resource Estimate
23rd Nov 20227:00 amRNSAgreement signed with Denarius Metals Corp.
9th Nov 20227:00 amRNSHighest Grade Drilling Results by the Company
7th Nov 20227:00 amRNSNotice of Annual General Meeting
1st Nov 202210:35 amRNSFinal Results for the Year Ended 30 June 2022
5th Oct 202212:00 pmRNSProposed US$6m Farm-In Arrangement re Toral
5th Sep 20227:00 amRNSHigh Grade Drilling Results
8th Aug 20221:30 pmRNSDirectors’ Dealings and Issue of Equity
4th Aug 20227:00 amRNSFurther Metallurgical Results & Operational Update
3rd May 20227:00 amRNSOperational Update
30th Mar 20227:00 amRNSResults for the Half-Year Ended 31 December 2021
23rd Mar 20227:00 amRNSPositive Ore Sorting Results for the Toral Project
23rd Feb 20227:00 amRNSToral Project Update and Director's Disclosure
3rd Feb 20227:00 amRNSDirectorate Change
26th Jan 20227:00 amRNSCorporate & Operational Update
13th Dec 20217:00 amRNSSuccessful Completion of Hydrogeological Programme
30th Nov 20211:00 pmRNSResults of AGM and Issue of Equity
18th Nov 20217:00 amRNSCorporate Review & Operational Update
8th Nov 20217:00 amRNSTranche 2 of Innovation Grant Drawn Down
3rd Nov 20213:12 pmRNSHolding(s) in Company
3rd Nov 20213:10 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotice of Annual General Meeting
29th Oct 20214:00 pmRNSFinal Results for the Year Ended 30 June 2021
26th Oct 20215:43 pmRNSResult of Fundraising
26th Oct 20217:00 amRNSFundraising and Appointment of Joint Broker
1st Oct 20217:00 amRNSUpdated Resource Estimate
7th Sep 20217:00 amRNSDrilling Results and Updated Resource Estimate
19th Jul 20217:00 amRNSMilestone 1 of CDTI Innovation Grant Completed
12th Jul 20213:06 pmRNSInvestor Webinar
22nd Jun 20217:00 amRNSWardell Armstrong Appointed as PFS Manager
7th Jun 20217:00 amRNSPFS Drilling Results - Toral Project, Spain
29th Apr 20217:00 amRNSDrilling Update Toral Zn, Pg & Ag Project, Spain
29th Mar 20217:30 amRNSResults for the Half-Year Ended 31 December 2020
16th Mar 20212:05 pmRNSSecond Price Monitoring Extn
16th Mar 20212:00 pmRNSPrice Monitoring Extension
15th Mar 202111:06 amRNSSecond Price Monitoring Extn
15th Mar 202111:01 amRNSPrice Monitoring Extension
27th Jan 20217:00 amRNSAppointment of Corporate Development Adviser
18th Jan 20217:00 amRNSPFS Update: Commencement of Drilling Campaign
18th Dec 20207:00 amRNSIssue of Options and Directors' Dealings
30th Nov 20201:15 pmRNSResults of Annual General Meeting
24th Nov 20207:00 amRNSInvestor Presentation
18th Nov 202012:00 pmRNSVideo fly through for the Toral Project
18th Nov 20207:00 amRNSResult from Independent Preliminary Economic Study
12th Nov 202011:00 amRNSRenewal of Investigation Permit for Toral Project
11th Nov 20204:41 pmRNSSecond Price Monitoring Extn
11th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.